Published in PLoS Pathog on December 08, 2011
Non-canonical translation in RNA viruses. J Gen Virol (2012) 2.50
Advances in norovirus biology. Cell Host Microbe (2014) 1.45
Norovirus. Clin Microbiol Rev (2015) 1.41
A single-amino-acid change in murine norovirus NS1/2 is sufficient for colonic tropism and persistence. J Virol (2012) 1.37
Protruding domain of capsid protein is necessary and sufficient to determine murine norovirus replication and pathogenesis in vivo. J Virol (2012) 1.34
Identification of immune and viral correlates of norovirus protective immunity through comparative study of intra-cluster norovirus strains. PLoS Pathog (2013) 1.22
Plasmid-based human norovirus reverse genetics system produces reporter-tagged progeny virus containing infectious genomic RNA. Proc Natl Acad Sci U S A (2014) 1.11
Persistent enteric murine norovirus infection is associated with functionally suboptimal virus-specific CD8 T cell responses. J Virol (2013) 1.05
Development of a reverse-genetics system for murine norovirus 3: long-term persistence occurs in the caecum and colon. J Gen Virol (2012) 1.04
Norovirus RNA synthesis is modulated by an interaction between the viral RNA-dependent RNA polymerase and the major capsid protein, VP1. J Virol (2012) 1.04
Viral proteins originated de novo by overprinting can be identified by codon usage: application to the "gene nursery" of Deltaretroviruses. PLoS Comput Biol (2013) 0.96
Deep sequencing of norovirus genomes defines evolutionary patterns in an urban tropical setting. J Virol (2014) 0.94
High-risk human papillomavirus E5 oncoprotein displays channel-forming activity sensitive to small-molecule inhibitors. J Virol (2012) 0.92
Identification of RNA-protein interaction networks involved in the norovirus life cycle. J Virol (2012) 0.92
Inactivation of norovirus on dry copper alloy surfaces. PLoS One (2013) 0.91
Reverse genetics mediated recovery of infectious murine norovirus. J Vis Exp (2012) 0.89
Structures of the compact helical core domains of feline calicivirus and murine norovirus VPg proteins. J Virol (2013) 0.89
The role of type I interferons in intestinal infection, homeostasis, and inflammation. Immunol Rev (2014) 0.89
ISG15 functions as an interferon-mediated antiviral effector early in the murine norovirus life cycle. J Virol (2014) 0.88
Development of a strand specific real-time RT-qPCR assay for the detection and quantitation of murine norovirus RNA. J Virol Methods (2012) 0.87
Influence of genome-scale RNA structure disruption on the replication of murine norovirus--similar replication kinetics in cell culture but attenuation of viral fitness in vivo. Nucleic Acids Res (2013) 0.86
Norovirus immunology: Of mice and mechanisms. Eur J Immunol (2015) 0.85
The influence of viral RNA secondary structure on interactions with innate host cell defences. Nucleic Acids Res (2013) 0.84
Relationship between genotypes and serotypes of genogroup 1 recoviruses: a model for human norovirus antigenic diversity. J Gen Virol (2014) 0.82
Norovirus vaccines and potential antinorovirus drugs: recent advances and future perspectives. Future Virol (2015) 0.82
Murine norovirus replication induces G0/G1 cell cycle arrest in asynchronously growing cells. J Virol (2015) 0.82
Functions of the 5' and 3' ends of calicivirus genomes. Virus Res (2015) 0.81
Murine norovirus 1 (MNV1) replication induces translational control of the host by regulating eIF4E activity during infection. J Biol Chem (2015) 0.81
High-resolution functional profiling of the norovirus genome. J Virol (2012) 0.81
Norovirus-mediated modification of the translational landscape via virus and host-induced cleavage of translation initiation factors. Mol Cell Proteomics (2017) 0.80
The feline calicivirus leader of the capsid protein is associated with cytopathic effect. J Virol (2012) 0.80
Molecular detection of murine noroviruses in laboratory and wild mice. Vet Microbiol (2012) 0.80
Structure determination of Murine Norovirus NS6 proteases with C-terminal extensions designed to probe protease-substrate interactions. PeerJ (2015) 0.80
Norovirus mechanisms of immune antagonism. Curr Opin Virol (2015) 0.79
Solenopsis invicta virus 3: mapping of structural proteins, ribosomal frameshifting, and similarities to Acyrthosiphon pisum virus and Kelp fly virus. PLoS One (2014) 0.79
Expression of the murine norovirus (MNV) ORF1 polyprotein is sufficient to induce apoptosis in a virus-free cell model. PLoS One (2014) 0.79
Translational Control during Calicivirus Infection. Viruses (2016) 0.78
The murine norovirus core subgenomic RNA promoter consists of a stable stem-loop that can direct accurate initiation of RNA synthesis. J Virol (2014) 0.78
Norovirus genome circularization and efficient replication are facilitated by binding of PCBP2 and hnRNP A1. J Virol (2013) 0.78
The human papillomavirus (HPV) E7 protein antagonises an Imiquimod-induced inflammatory pathway in primary human keratinocytes. Sci Rep (2015) 0.77
Reinitiation after translation of two upstream open reading frames (ORF) governs expression of the ORF35-37 Kaposi's sarcoma-associated herpesvirus polycistronic mRNA. J Virol (2014) 0.77
Vesivirus 2117 capsids more closely resemble sapovirus and lagovirus particles than other known vesivirus structures. J Gen Virol (2016) 0.77
Biochemical Evaluation of the Inhibition Properties of Favipiravir and 2'-C-Methyl-Cytidine Triphosphates against Human and Mouse Norovirus RNA Polymerases. Antimicrob Agents Chemother (2015) 0.77
Feline calicivirus can tolerate gross changes of its minor capsid protein expression levels induced by changing translation reinitiation frequency or use of a separate VP2-coding mRNA. PLoS One (2014) 0.76
Norovirus antagonism of B-cell antigen presentation results in impaired control of acute infection. Mucosal Immunol (2016) 0.76
Regulation of Norovirus Virulence by the VP1 Protruding Domain Correlates with B Cell Infection Efficiency. J Virol (2015) 0.76
Norovirus in symptomatic and asymptomatic individuals: cytokines and viral shedding. Clin Exp Immunol (2016) 0.76
Porcine sapovirus replication is restricted by the type I interferon response in cell culture. J Gen Virol (2014) 0.76
Subgenomic promoter recognition by the norovirus RNA-dependent RNA polymerases. Nucleic Acids Res (2014) 0.76
Current Status of Norovirus Infections in Children in Sub-Saharan Africa. J Trop Med (2015) 0.75
Recent advances in understanding noroviruses. F1000Res (2017) 0.75
Proteomic Analysis of the Schistosoma mansoni Miracidium. PLoS One (2016) 0.75
Transcriptomic analysis of human norovirus NS1-2 protein highlights a multifunctional role in murine monocytes. BMC Genomics (2017) 0.75
Murine norovirus infection in Brazilian animal facilities. Exp Anim (2016) 0.75
Norovirus Regulation by Host and Microbe. Trends Mol Med (2016) 0.75
Expression of the NS5 (VPg) Protein of Murine Norovirus Induces a G1/S Phase Arrest. PLoS One (2016) 0.75
Infection with the Persistent Murine Norovirus Strain MNV-S99 Suppresses IFN-Beta Release and Activation of Stat1 In Vitro. PLoS One (2016) 0.75
Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB. J Transl Med (2016) 0.75
Effect of TERT on the growth of fibrosarcoma via caspase-3, survivin and PKB. Oncol Lett (2017) 0.75
Viral Population Changes during Murine Norovirus Propagation in RAW 264.7 Cells. Front Microbiol (2017) 0.75
Histologic Lesions Induced by Murine Norovirus Infection in Laboratory Mice. Vet Pathol (2016) 0.75
Interferon-Lambda: A Potent Regulator of Intestinal Viral Infections. Front Immunol (2017) 0.75
Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell (2005) 20.30
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol (2005) 18.32
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature (2005) 17.47
VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell (2005) 14.20
A novel influenza A virus mitochondrial protein that induces cell death. Nat Med (2001) 9.90
Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology (1998) 9.81
Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science (2003) 7.91
Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell (2010) 6.79
Replication of Norovirus in cell culture reveals a tropism for dendritic cells and macrophages. PLoS Biol (2004) 6.35
STAT1-dependent innate immunity to a Norwalk-like virus. Science (2003) 6.35
Selection of initiation sites by eucaryotic ribosomes: effect of inserting AUG triplets upstream from the coding sequence for preproinsulin. Nucleic Acids Res (1984) 5.96
Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe (2007) 5.46
A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog (2007) 4.99
Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog (2005) 3.44
Ribosomal frameshifting viral RNAs. J Gen Virol (1995) 2.86
Murine noroviruses comprising a single genogroup exhibit biological diversity despite limited sequence divergence. J Virol (2007) 2.84
Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses. J Virol (2007) 2.68
Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms. PLoS Pathog (2007) 2.54
Viral apoptosis is induced by IRF-3-mediated activation of Bax. EMBO J (2010) 2.36
Development of a microsphere-based serologic multiplexed fluorescent immunoassay and a reverse transcriptase PCR assay to detect murine norovirus 1 infection in mice. Clin Diagn Lab Immunol (2005) 2.25
Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J Virol (2005) 2.17
Cleavage map and proteolytic processing of the murine norovirus nonstructural polyprotein in infected cells. J Virol (2006) 2.10
Calicivirus translation initiation requires an interaction between VPg and eIF 4 E. EMBO Rep (2005) 1.98
Innate cellular response to virus particle entry requires IRF3 but not virus replication. J Virol (2004) 1.91
The genome-linked protein VPg of the Norwalk virus binds eIF3, suggesting its role in translation initiation complex recruitment. EMBO J (2003) 1.84
The NPro product of bovine viral diarrhea virus inhibits DNA binding by interferon regulatory factor 3 and targets it for proteasomal degradation. J Virol (2006) 1.84
Immune mechanisms responsible for vaccination against and clearance of mucosal and lymphatic norovirus infection. PLoS Pathog (2008) 1.69
Antibody is critical for the clearance of murine norovirus infection. J Virol (2008) 1.69
MDA-5 recognition of a murine norovirus. PLoS Pathog (2008) 1.68
Initiation at the third in-frame AUG codon of open reading frame 3 of the hepatitis E virus is essential for viral infectivity in vivo. J Virol (2007) 1.68
Recovery of infectious murine norovirus using pol II-driven expression of full-length cDNA. Proc Natl Acad Sci U S A (2007) 1.68
MAVS-mediated apoptosis and its inhibition by viral proteins. PLoS One (2009) 1.67
The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses. J Virol (2006) 1.66
Bioinformatic and functional analysis of RNA secondary structure elements among different genera of human and animal caliciviruses. Nucleic Acids Res (2008) 1.63
Detecting overlapping coding sequences in virus genomes. BMC Bioinformatics (2006) 1.61
V and C proteins of measles virus function as virulence factors in vivo. Virology (2000) 1.61
Human enteric caliciviruses have a unique genome structure and are distinct from the Norwalk-like viruses. Arch Virol (1995) 1.60
Caliciviruses differ in their functional requirements for eIF4F components. J Biol Chem (2006) 1.60
The interferon stimulated gene 54 promotes apoptosis. J Biol Chem (2010) 1.58
STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor. PLoS Pathog (2011) 1.54
Recovery of genetically defined murine norovirus in tissue culture by using a fowlpox virus expressing T7 RNA polymerase. J Gen Virol (2007) 1.54
Influenza A virus PB1-F2: a small protein with a big punch. Cell Host Microbe (2007) 1.49
A point mutation in the Sendai virus accessory C proteins attenuates virulence for mice, but not virus growth in cell culture. Virology (1997) 1.47
Murine norovirus: an intercurrent variable in a mouse model of bacteria-induced inflammatory bowel disease. Comp Med (2008) 1.44
Non-AUG-initiated internal translation of the L* protein of Theiler's virus and importance of this protein for viral persistence. J Virol (2002) 1.41
Induction and mode of action of the viral stress-inducible murine proteins, P56 and P54. Virology (2005) 1.40
Detecting overlapping coding sequences with pairwise alignments. Bioinformatics (2004) 1.39
Optineurin negatively regulates the induction of IFNbeta in response to RNA virus infection. PLoS Pathog (2010) 1.39
Genetic diversity and recombination of murine noroviruses in immunocompromised mice. Arch Virol (2007) 1.37
The evolution of genome compression and genomic novelty in RNA viruses. Genome Res (2007) 1.36
Cellular localization of the herpes simplex virus ICP0 protein dictates its ability to block IRF3-mediated innate immune responses. PLoS One (2010) 1.28
Endocytosis of murine norovirus 1 into murine macrophages is dependent on dynamin II and cholesterol. J Virol (2010) 1.27
Herpesviruses and the innate immune response. Viral Immunol (2005) 1.27
Close spacing of AUG initiation codons confers dicistronic character on a eukaryotic mRNA. RNA (2006) 1.24
The PB1-F2 protein of Influenza A virus: increasing pathogenicity by disrupting alveolar macrophages. Virol J (2007) 1.24
Paramyxovirus disruption of interferon signal transduction: STATus report. J Interferon Cytokine Res (2009) 1.21
A single amino acid substitution in the murine norovirus capsid protein is sufficient for attenuation in vivo. J Virol (2008) 1.19
Type I and type II interferons inhibit the translation of murine norovirus proteins. J Virol (2009) 1.18
Development of an optimized RNA-based murine norovirus reverse genetics system. J Virol Methods (2010) 1.17
Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system. Hepatology (2010) 1.15
N(pro) of classical swine fever virus is an antagonist of double-stranded RNA-mediated apoptosis and IFN-alpha/beta induction. Virology (2005) 1.13
Effect of murine norovirus infection on mouse parvovirus infection. J Am Assoc Lab Anim Sci (2010) 1.10
Primary high-dose murine norovirus 1 infection fails to protect from secondary challenge with homologous virus. J Virol (2009) 1.06
Apoptosis in murine norovirus-infected RAW264.7 cells is associated with downregulation of survivin. J Virol (2009) 1.04
Investigation of the impact of the common animal facility contaminant murine norovirus on experimental murine cytomegalovirus infection. Virology (2009) 1.04
Effects of acute and chronic murine norovirus infections on immune responses and recovery from Friend retrovirus infection. J Virol (2009) 1.04
Murine norovirus-1 cell entry is mediated through a non-clathrin-, non-caveolae-, dynamin- and cholesterol-dependent pathway. J Gen Virol (2010) 1.04
Putting the brakes on the anti-viral response: negative regulators of type I interferon (IFN) production. Microbes Infect (2011) 1.03
Functional analysis of RNA structures present at the 3' extremity of the murine norovirus genome: the variable polypyrimidine tract plays a role in viral virulence. J Virol (2010) 1.03
Tom70 mediates activation of interferon regulatory factor 3 on mitochondria. Cell Res (2010) 1.02
Expression of the VP2 protein of murine norovirus by a translation termination-reinitiation strategy. PLoS One (2009) 0.97
Hepatitis B virus X gene is implicated in liver carcinogenesis. Cancer Lett (2009) 0.97
Effects of murine norovirus infection on a mouse model of diet-induced obesity and insulin resistance. Comp Med (2010) 0.95
Access of viral proteins to mitochondria via mitochondria-associated membranes. Rev Med Virol (2009) 0.95
Molecular basis of cellular localization of poly C binding protein 1 in neuronal cells. Biochem Biophys Res Commun (2006) 0.91
Leaky ribosomal scanning in mammalian genomes: significance of histone H4 alternative translation in vivo. Nucleic Acids Res (2005) 0.90
Expression of the NS3 protease of cytopathogenic bovine viral diarrhea virus results in the induction of apoptosis but does not block activation of the beta interferon promoter. J Gen Virol (2009) 0.88
Cysteine protease activation and apoptosis in Murine norovirus infection. Virol J (2009) 0.86
Theiler's virus L protein is targeted to the mitochondrial outer membrane. J Virol (2011) 0.82
Subcellular localizations of the hepatitis C virus alternate reading frame proteins. Virus Res (2008) 0.81
Leader (L) and L* proteins of Theiler's murine encephalomyelitis virus (TMEV) and their regulation of the virus' biological activities. J Neuroinflammation (2006) 0.77
Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. N Engl J Med (2005) 5.54
New DNA viruses identified in patients with acute viral infection syndrome. J Virol (2005) 5.26
Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature (2012) 4.41
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology (2014) 4.15
Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med (2006) 3.63
An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses. J Exp Med (2008) 3.42
Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer. N Engl J Med (2006) 3.36
A newly identified bocavirus species in human stool. J Infect Dis (2009) 3.25
A highly prevalent and genetically diversified Picornaviridae genus in South Asian children. Proc Natl Acad Sci U S A (2008) 3.12
Toxoplasma profilin is essential for host cell invasion and TLR11-dependent induction of an interleukin-12 response. Cell Host Microbe (2008) 2.80
Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel. PLoS Med (2008) 2.74
Gut commensal bacteria direct a protective immune response against Toxoplasma gondii. Cell Host Microbe (2009) 2.67
Human bocaviruses are highly diverse, dispersed, recombination prone, and prevalent in enteric infections. J Infect Dis (2010) 2.66
Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus. J Infect Dis (2007) 2.57
Reactivation and mutation of newly discovered WU, KI, and Merkel cell carcinoma polyomaviruses in immunosuppressed individuals. J Infect Dis (2009) 2.28
The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae. J Gen Virol (2010) 2.26
Thermodynamic and phylogenetic prediction of RNA secondary structures in the coding region of hepatitis C virus. RNA (2002) 2.20
Characterization of a canine homolog of hepatitis C virus. Proc Natl Acad Sci U S A (2011) 2.14
The fecal virome of pigs on a high-density farm. J Virol (2011) 2.03
High variety of known and new RNA and DNA viruses of diverse origins in untreated sewage. J Virol (2012) 2.03
Calicivirus translation initiation requires an interaction between VPg and eIF 4 E. EMBO Rep (2005) 1.98
A comparative method for finding and folding RNA secondary structures within protein-coding regions. Nucleic Acids Res (2004) 1.89
Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis. J Infect Dis (2004) 1.85
Proposals for the classification of human rhinovirus species A, B and C into genotypically assigned types. J Gen Virol (2013) 1.82
Gammadelta intraepithelial lymphocytes are essential mediators of host-microbial homeostasis at the intestinal mucosal surface. Proc Natl Acad Sci U S A (2011) 1.80
Serology-enabled discovery of genetically diverse hepaciviruses in a new host. J Virol (2012) 1.80
Virologic and clinical features of primary infection with human parvovirus 4 in subjects with hemophilia: frequent transmission by virally inactivated clotting factor concentrates. Transfusion (2011) 1.79
High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies. J Infect Dis (2009) 1.78
Nomenclature and numbering of the hepatitis C virus. Methods Mol Biol (2009) 1.75
The hepatitis C virus epidemic among injecting drug users. Infect Genet Evol (2005) 1.70
Toxoplasma gondii rhoptry kinase ROP16 activates STAT3 and STAT6 resulting in cytokine inhibition and arginase-1-dependent growth control. PLoS Pathog (2011) 1.67
A comprehensive system for consistent numbering of HCV sequences, proteins and epitopes. Hepatology (2006) 1.65
Bioinformatic and functional analysis of RNA secondary structure elements among different genera of human and animal caliciviruses. Nucleic Acids Res (2008) 1.63
EV02: a Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone. Vaccine (2008) 1.62
Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant. J Immunol (2005) 1.62
Identification of rodent homologs of hepatitis C virus and pegiviruses. MBio (2013) 1.61
Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection. Blood (2012) 1.60
Analysis of genetic diversity and sites of recombination in human rhinovirus species C. J Virol (2010) 1.60
The Hepatitis C virus NS5A protein activates a phosphoinositide 3-kinase-dependent survival signaling cascade. J Biol Chem (2004) 1.60
Non-macrophage-tropic human immunodeficiency virus type 1 R5 envelopes predominate in blood, lymph nodes, and semen: implications for transmission and pathogenesis. J Virol (2006) 1.58
Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections. J Immunol (2010) 1.53
Accelerated Tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy. Acta Neuropathol (2006) 1.52
A novel diagnostic target in the hepatitis C virus genome. PLoS Med (2009) 1.52
Therapeutic helminth infection of macaques with idiopathic chronic diarrhea alters the inflammatory signature and mucosal microbiota of the colon. PLoS Pathog (2012) 1.52
B cell-intrinsic MyD88 signaling prevents the lethal dissemination of commensal bacteria during colonic damage. Immunity (2012) 1.47
Plasmacytoid dendritic cells are activated by Toxoplasma gondii to present antigen and produce cytokines. J Immunol (2008) 1.45
Widespread infection with homologues of human parvoviruses B19, PARV4, and human bocavirus of chimpanzees and gorillas in the wild. J Virol (2010) 1.42
Parasite-induced TH1 cells and intestinal dysbiosis cooperate in IFN-γ-dependent elimination of Paneth cells. Nat Immunol (2012) 1.41
Optineurin negatively regulates the induction of IFNbeta in response to RNA virus infection. PLoS Pathog (2010) 1.39
Rapid sequence change and geographical spread of human parvovirus B19: comparison of B19 virus evolution in acute and persistent infections. J Virol (2008) 1.39
Structural insights into the transcriptional and translational roles of Ebp1. EMBO J (2007) 1.37
Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors. Retrovirology (2008) 1.37
Critical coordination of innate immune defense against Toxoplasma gondii by dendritic cells responding via their Toll-like receptors. Proc Natl Acad Sci U S A (2010) 1.37
Human parvovirus 4 as potential cause of encephalitis in children, India. Emerg Infect Dis (2011) 1.36
Genetic variability and the classification of hepatitis E virus. J Virol (2013) 1.36
Changing epidemiology of human parvovirus 4 infection in sub-Saharan Africa. Emerg Infect Dis (2010) 1.36
TT virus infection: a novel virus-host relationship. J Med Microbiol (2002) 1.36
Early protection against pathogenic virus infection at a mucosal challenge site after vaccination with attenuated simian immunodeficiency virus. Proc Natl Acad Sci U S A (2004) 1.30
Genetics, recombination and clinical features of human rhinovirus species C (HRV-C) infections; interactions of HRV-C with other respiratory viruses. PLoS One (2009) 1.30
Bioinformatic and physical characterizations of genome-scale ordered RNA structure in mammalian RNA viruses. J Virol (2008) 1.29
Nonprimate hepaciviruses in domestic horses, United kingdom. Emerg Infect Dis (2012) 1.28
EV01: a phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium. Vaccine (2008) 1.25
UNC93B1 is essential for TLR11 activation and IL-12-dependent host resistance to Toxoplasma gondii. J Biol Chem (2010) 1.25
Discovery and characterization of mammalian endogenous parvoviruses. J Virol (2010) 1.23
Detection and genetic characterization of enteroviruses circulating among wild populations of chimpanzees in Cameroon: relationship with human and simian enteroviruses. J Virol (2011) 1.23
A hepatitis C virus cis-acting replication element forms a long-range RNA-RNA interaction with upstream RNA sequences in NS5B. J Virol (2008) 1.22
Serodiagnosis of primary infections with human parvovirus 4, Finland. Emerg Infect Dis (2011) 1.22
Induction of adaptive immunity by flagellin does not require robust activation of innate immunity. Eur J Immunol (2009) 1.19
Characterization of a canine homolog of human Aichivirus. J Virol (2011) 1.18
Topoisomerase-II alpha expression as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel. Mol Cancer Ther (2004) 1.17
Development of an optimized RNA-based murine norovirus reverse genetics system. J Virol Methods (2010) 1.17
Parechoviruses in children: understanding a new infection. Curr Opin Infect Dis (2010) 1.17
Allelic variation of HERV-K(HML-2) endogenous retroviral elements in human populations. J Mol Evol (2004) 1.16
A genetic analysis of hepatitis C virus transmission between injection drug users. J Infect Dis (2002) 1.16
Introduction of replication-competent hepatitis C virus transcripts using a tetracycline-regulable baculovirus delivery system. J Gen Virol (2004) 1.15
Innate responses to Toxoplasma gondii in mice and humans. Trends Parasitol (2011) 1.15
B cell TLR7 expression drives anti-RNA autoantibody production and exacerbates disease in systemic lupus erythematosus-prone mice. J Immunol (2012) 1.13
Hepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular beta-catenin and stimulation of beta-catenin-responsive transcription. J Virol (2005) 1.13
Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study. J Natl Cancer Inst (2013) 1.13
When should "I" consider a new hepatitis B virus genotype? J Virol (2008) 1.13
Prospective study of Outcomes in Sporadic versus Hereditary breast cancer (POSH): study protocol. BMC Cancer (2007) 1.12
Microbial infection-induced expansion of effector T cells overcomes the suppressive effects of regulatory T cells via an IL-2 deprivation mechanism. J Immunol (2011) 1.11
The influence of genetic variation in 30 selected genes on the clinical characteristics of early onset breast cancer. Breast Cancer Res (2008) 1.11
Novel positive-sense, single-stranded RNA (+ssRNA) virus with di-cistronic genome from intestinal content of freshwater carp (Cyprinus carpio). PLoS One (2011) 1.10
Suppression of a pro-apoptotic K+ channel as a mechanism for hepatitis C virus persistence. Proc Natl Acad Sci U S A (2009) 1.10
Next-generation whole genome sequencing identifies the direction of norovirus transmission in linked patients. Clin Infect Dis (2013) 1.10
Evaluating the evidence for virus/host co-evolution. Curr Opin Virol (2011) 1.09
Genotype differences in susceptibility and resistance development of hepatitis C virus to protease inhibitors telaprevir (VX-950) and danoprevir (ITMN-191). Hepatology (2011) 1.08
Identification of a pegivirus (GB virus-like virus) that infects horses. J Virol (2013) 1.08
Comparison of human parechovirus and enterovirus detection frequencies in cerebrospinal fluid samples collected over a 5-year period in edinburgh: HPeV type 3 identified as the most common picornavirus type. J Med Virol (2011) 1.07